Amoxiclav URTI RWE
A multicenter, retrospective, real world evidence study to evaluate the effectiveness of Co-Amoxiclav in the management of patients suffering from Upper Respiratory Tract Infections (URTIs)
ASSESSMENT 1 - BASELINE VISIT - DAY 0
DEMOGRAPHICS and ANTHROPOMETRY
MEDICAL AND SURGICAL HISTORY
CONCOMITANT DISEASE and MEDICATION
MICROBIOLOGICAL DATA
VITALS
LABORATORY PARAMETERS (Reports & Value)
TREATMENT OF CURRENT MEDICAL ILLNESS
| Medication | Dose | Frequency | Duration |
|---|---|---|---|
|
|
|
|
|
ASSESSMENT 2 - FIRST FOLLOW-UP VISIT - DAY 7±2
DATE OF ASSESSMENT
MICROBIOLOGICAL DATA
VITALS
LABORATORY PARAMETERS (Reports & Value)
CLINICAL DATA